Pharma Journalist - Page 83 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

RedHill Licenses RHB-102 to Hyloris for Global Commercialization, Potentially Worth $60M

Summit Therapeutics Partners with Pfizer to Trial Ivonescimab with ADCs

Mirum’s CTEXLI Tablets FDA-Approved for Cerebrotendinous Xanthomatosis

FDA Accepts BMS’ SBLAs for Opdivo + Yervoy in MSI-High, MMR-D Cancer

EMA Validates Gilead’s Application for Twice-Yearly Lenacapavir as HIV Prevention

Teva and Alvotech Launch SELARSDI Injection in the U.S.

Boehringer’s Zongertinib Gets U.S. FDA Priority Review for HER2-Mutant Advanced NSCLC

FDA Grants ImmunityBio Approval to Supply Recombinant BCG (rBCG) Amid TICE BCG Shortage

Rznomics Inc. Liver Cancer Drug Receives Fast Track Designation

FDA Accepts Dupixent sBLA for Bullous Pemphigoid Treatment under Priority Review